GSK CTO, Boehringer Exec On The Metaverse And Pharma’s Foot In The Door
GSK Has Seen ' Lot Of Success' With Bots
Big pharma executives discuss the transformative potential of the metaverse in the life sciences segment and how things are shaping in the virtual world amid the hype. GSK’s senior VP and chief technology officer outlines to Scrip gains made deploying digital twins and bots.
